RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Intermediate Medical Writing: Pharmaceuticals and Biologics [3.0 RAC]

3.0 RAC Credits Online Course Online Course Pharmaceutical Certificate Elective Pharmaceutical Certificate Elective Member: $365.00 Nonmember: $500.00

Intermediate Medical Writing: Pharmaceuticals and Biologics [3.0 RAC]
Regulatory and medical writing is an integral part of the product development and approval process and plays a crucial role in assuring that submissions for new products are well organized, accurate and reviewer-friendly.

This course will provide an overview of some of the more complex documents prepared by regulatory and medical writers, with a focus on the Common Technical Document (CTD). Key considerations associated with writing submissions in CTD format, including region-specific considerations for clinical sections in US New Drug Applications (NDA), US Biologics License Applications (BLA) and EU Marketing Authorisation Applications (MAA) will be discussed. You will be introduced to the components of each of these application types and learn techniques for improving document quality in order to advance your career as a medical writer.

At a Glance
  • Target Audience: Professionals with one to three years’ experience in medical writing and those who need a basic introduction to the regulatory documents discussed.
  • Learning Level: Basic
  • Total Length of Course: 3 Hours
  • RAC Points: 3

Learning Objectives

Upon completion of this course, participants should be able to:
  • Explain the modules contained within the CTD, including regional variations and considerations for document submission
  • Describe and understand the contents of the clinical sections of an NDA, BLA and MAA
  • Formulate a plan for preparing these documents and understand where to seek further guidance Identify factors that may affect the quality of regulatory documents and strategies to improve their quality

Lesson Titles
  • Lesson 1: Common Technical Document (CTD)
  • Lesson 2: New Drugs Application (NDA)
  • Lesson 3: Biological License Application (BLA)
  • Lesson 4: Marketing Authorisation Application (MAA)

Enrollment Period: 6 months
Add to Cart